Prevention of Major Depression: A Global Priority




© Springer Science+Business Media New York 2015
Olivia I. Okereke (ed.)Prevention of Late-Life DepressionAging Medicine910.1007/978-3-319-16045-0_1


1. Prevention of Major Depression: A Global Priority



Charles F. ReynoldsIII1, 2, 3, 4  


(1)
Department of Clinical Psychology, EMGO Institute for Health and Care Research, VU University, Van der Boechorststraat 1, Amsterdam, 1081 BT, The Netherlands

(2)
Department of Psychiatry, EMGO Institute for Health and Care Research, VU University, Amsterdam, The Netherlands

(3)
Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

(4)
Department of Behavioral and Community Health Sciences, Graduate School of Public Health, Pittsburgh, PA, USA

 



 

Charles F. ReynoldsIII



Abstract

Prevention of depression and its associated common mental disorders is a priority across the life cycle, and particularly in older adults. Currently available data from randomized clinical trials show that the rate of these disorders can be reduced on average 20–25 % over 1–2 years of follow-up. This is important with respect to: (1) reducing the current burden of suffering, even in the context of subsyndromal symptoms and (2) protection from fully syndromal depression and its down-stream consequences, including poor adherence with co-prescribed medical and behavioral interventions (because depression undermines adherence), family care–giving burden (because depression imposes considerable burden on family as well as patients), suicide (because depression is a major risk factor for suicide in older patients), and dementia (because depression is an important and potentially modifiable risk factor for both vascular and Alzheimer’s dementia). Additional work is needed to clarify biological and psychosocial mediators and moderators of depression prevention intervention; and to build scalable models of depression prevention for low-resource countries.


Keywords
DepressionIndicated preventionOlder adults


Prevention of common mental disorders, particularly major depression, represents one of the grand challenges in global mental health (grandchallengesinglobalMH@NIH.org). Meta-analyses of more than 30 randomized trials conducted in the High Income Countries show that the incidence of new depressive and anxiety disorders can be reduced by 25–50 % over 1–2 years, compared to usual care, through the use of learning-based psychotherapies (such as interpersonal psychotherapy, cognitive behavioral therapy, and problem solving therapy) [1, 2]. In addition, a recent study, the MANAS trial (“project to promote mental health” in the Konkani language), conducted in Goa, India, demonstrated that the use of lay health counselors, as part of a collaborative stepped-care intervention, not only increased recovery rates from common mental disorders (anxiety and depression) in a mixed aged sample of patients attending public primary care facilities [3] but also reduced the incidence of common mental disorders in those presenting initially with subsyndromal symptoms of depression and anxiety. The MANAS trial was particularly important from the perspective of workforce issues. That is, given the shortage of mental health specialists in Low and Middle Income Countries (LMICs), MANAS demonstrated the advantage of task shifting, that is, the rational redistribution of tasks among health workforce teams in order to make more efficient use of lay and professional human resources.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 25, 2017 | Posted by in PSYCHOLOGY | Comments Off on Prevention of Major Depression: A Global Priority

Full access? Get Clinical Tree

Get Clinical Tree app for offline access